Label: ATENOLOL AND CHLORTHALIDONE tablet

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated June 25, 2024

If you are a consumer or patient please visit this version.

  • DESCRIPTION
    Atenolol and chlorthalidone tablets, USP are for the treatment of hypertension. It combines the antihypertensive activity of two agents: a beta - 1-selective (cardioselective) hydrophilic ...
  • CLINICAL PHARMACOLOGY
    Atenolol and Chlorthalidone - Atenolol and chlorthalidone have been used singly and concomitantly for the treatment of hypertension. The antihypertensive effects of these agents are additive ...
  • INDICATIONS AND USAGE
    Atenolol and chlorthalidone tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events ...
  • CONTRAINDICATIONS
    Atenolol and chlorthalidone tablets are contraindicated in patients with: sinus bradycardia; heart block greater than first degree; cardiogenic shock; overt cardiac failure (see - WARNINGS) ...
  • WARNINGS
    Cardiac Failure - Sympathetic stimulation is necessary in supporting circulatory function in congestive heart failure, and beta blockade carries the potential hazard of further depressing ...
  • PRECAUTIONS
    General - Atenolol and chlorthalidone tablets may aggravate peripheral arterial circulatory disorders. Information for Patients - Hypoglycemia - Inform patients or caregivers that there is a ...
  • ADVERSE REACTIONS
    Atenolol and chlorthalidone tablets are usually well tolerated in properly selected patients. Most adverse effects have been mild and transient. The adverse effects observed for atenolol and ...
  • POTENTIAL ADVERSE EFFECTS
    In addition, a variety of adverse effects not observed in clinical trials with atenolol but reported with other beta-adrenergic blocking agents should be considered potential adverse effects of ...
  • OVERDOSAGE
    No specific information is available with regard to overdosage and atenolol and chlorthalidone tablets in humans. Treatment should be symptomatic and supportive and directed to the removal of any ...
  • DOSAGE AND ADMINISTRATION
    DOSAGE MUST BE INDIVIDUALIZED. (See - INDICATIONS AND USAGE.) Chlorthalidone is usually given at a dose of 25 mg daily; the usual initial dose of atenolol is 50 mg daily. Therefore, the ...
  • HOW SUPPLIED
    Atenolol and chlorthalidone tablets, USP  100 mg/25 mg, are light yellow colored, round shaped, biconvex, uncoated tablet debossed with '26' on one side and 'U' on the other side, supplied in - NDC ...
  • PRINCIPAL DISPLAY PANEL
    DRUG: Atenolol and Chlorthalidone - GENERIC: Atenolol and Chlorthalidone - DOSAGE: TABLET - ADMINSTRATION: ORAL - NDC: 70518-4111-0 - COLOR: yellow - SHAPE: ROUND - SCORE: No score - SIZE: 9 mm - IMPRINT ...
  • INGREDIENTS AND APPEARANCE
    Product Information